Cargando…

Sarcopenia and diabetes: Hyperglycemia is a risk factor for age-associated muscle mass and functional reduction

Detalles Bibliográficos
Autor principal:	Umegaki, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627537/ https://www.ncbi.nlm.nih.gov/pubmed/26543534 http://dx.doi.org/10.1111/jdi.12365

Ejemplares similares

Diabetes‐related cognitive dysfunction: Hyperglycemia in the early stage might be a key?
por: Umegaki, Hiroyuki
Publicado: (2018)

Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus
por: Sugimoto, Ken, et al.
Publicado: (2019)

Diabetes Management and Hyperglycemia in Safety Sensitive Jobs
por: Lee, See-Muah, et al.
Publicado: (2011)

Advanced Skeletal Muscle Mass Reduction (Sarcopenia) Secondary to Neuromuscular Disease
por: Pesola, G. R., et al.
Publicado: (2020)

Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
por: Esposito, Katherine, et al.
Publicado: (2013)

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013)

The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men
por: Franzon, Kristin, et al.
Publicado: (2019)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

The Associations among Insulin Resistance, Hyperglycemia, Physical Performance, Diabetes Mellitus, and Cognitive Function in Relatively Healthy Older Adults with Subtle Cognitive Dysfunction
por: Umegaki, Hiroyuki, et al.
Publicado: (2017)

Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
por: Ticinesi, Andrea, et al.
Publicado: (2019)

Type 2 diabetes as a risk factor for cognitive impairment: current insights
por: Umegaki, Hiroyuki
Publicado: (2014)

Sarcopenia: Molecular regulatory network for loss of muscle mass and function
por: Wu, Jiaxiang, et al.
Publicado: (2023)

Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis
por: Eckold, Clare, et al.
Publicado: (2020)

Low muscle mass, low muscle function, and sarcopenia in the urban and rural elderly
por: Moon, Sung Woo, et al.
Publicado: (2022)

Skeletal muscle mass and mortality - but what about functional outcome?
por: Puthucheary, Zudin A, et al.
Publicado: (2014)

Implications of Race and Ethnicity in Sarcopenia US National Prevalence of Sarcopenia by Muscle Mass, Strength, and Function Indices
por: G, Bigman, et al.
Publicado: (2021)

Management of Diabetes Mellitus: Could Simultaneous Targeting of Hyperglycemia and Oxidative Stress Be a Better Panacea?
por: Erejuwa, Omotayo O.
Publicado: (2012)

Editor’s choice: sarcopenia or loss of muscle mass
por: Walker, Richard F
Publicado: (2012)

Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus
por: Ogama, Noriko, et al.
Publicado: (2019)

Muscle Changes in Aging: Understanding Sarcopenia
por: Siparsky, Patrick N., et al.
Publicado: (2014)

Sarcopenia: burden and challenges for public health
por: Beaudart, Charlotte, et al.
Publicado: (2014)

Prediabetes is associated with loss of appendicular skeletal muscle mass and sarcopenia
por: Li, Shuying, et al.
Publicado: (2023)

Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function
por: dos Santos, Leandro, et al.
Publicado: (2016)

Hyperglycemia in the intensive care unit: is insulin the only option?
por: Dungan, Kathleen M
Publicado: (2013)

Hyperglycemia diverts dividing stem cells to pathological adipogenesis
por: Hascall, Vincent, et al.
Publicado: (2014)

Increasing muscle mass to improve metabolism
por: McPherron, Alexandra C., et al.
Publicado: (2013)

The Intriguing Regulators of Muscle Mass in Sarcopenia and Muscular Dystrophy
por: Sakuma, Kunihiro, et al.
Publicado: (2014)

New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia
por: Moon, Jeong Jae, et al.
Publicado: (2018)

Muscle Mass Assessment in Sarcopenia: A Narrative Review
por: Muraki, Isao
Publicado: (2023)

Comparative associations of diabetes risk factors with five measures of hyperglycemia
por: Poon, Anna K, et al.
Publicado: (2014)

Prevalence of sarcopenia under different diagnostic criteria and the changes in muscle mass, muscle strength, and physical function with age in Chinese old adults
por: Cao, Mengyu, et al.
Publicado: (2022)

Sarcopenia definition, diagnosis and treatment: consensus is growing
por: Sayer, Avan Aihie, et al.
Publicado: (2022)

High Salt Diet Impacts the Risk of Sarcopenia Associated with Reduction of Skeletal Muscle Performance in the Japanese Population
por: Yoshida, Yasuko, et al.
Publicado: (2020)

Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms
por: Callahan, Leigh Ann, et al.
Publicado: (2009)

COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Lactobacillus plantarum HY7715 Ameliorates Sarcopenia by Improving Skeletal Muscle Mass and Function in Aged Balb/c Mice
por: Lee, Kippeum, et al.
Publicado: (2021)

Relationship between quadriceps muscle computed tomography measurement and motor function, muscle mass, and sarcopenia diagnosis
por: Mizuno, Takafumi, et al.
Publicado: (2023)

Body mass index, type 2 diabetes, and left ventricular function
por: Musaeus, Katrine Dina, et al.
Publicado: (2018)

Sarcopenia and Muscle Aging: A Brief Overview
por: Dao, Tam, et al.
Publicado: (2020)

Some clarifications of terminology may facilitate sarcopenia assessment
por: Lewandowicz, Andrzej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oi60d344b61pu345khqefem4gu